Table 5 The relation between the clinical presentations of BD patients and the studied laboratory data (n = 36)
Clinical presentation | NLR | PLR | LMR | MPV | ESR | CRP |
|---|---|---|---|---|---|---|
Muco-cutaneous involvement | ||||||
• No | 1.80 (0.77–9.60)* | 9.90 (6.60–27.30)* | 0.13 (0.07–0.25)* | 7.7 (6.8–9.4) | 28.0 (10.0–110.0) | 2.67 (1.20–3.50)* |
• Yes | 3.80 (0.40–5.40) | 13.30 (4.20–18.90) | 0.08 (0.01–0.30) | 8.3 (6.4–9.3) | 36.0 (9.0–141.0) | 13.20 (1.09–60.0) |
Articular involvement | ||||||
• No | 3.80 (0.40–9.60) | 14.70 (4.20–27.30) | 0.09 (0.03–0.30) | 9.1 (6.4–9.4)* | 36.0 (9.0–141.0) | 7.73 (1.60–60.0) |
• Yes | 2.60 (1.00–4.70) | 9.90 (6.60–15.50) | 0.10 (0.01–0.18) | 7.7 (7.3–9.0) | 28.0 (10.0–131.0) | 2.67 (1.09–24.0) |
Gastrointestinal involvement | ||||||
• No | 2.60 (0.40–9.60) | 10.90 (4.20–27.30) | 0.10 (0.01–0.30)* | 8.1 (6.4–9.4) | 29.5 (9.0–141.0) | 3.11 (1.20–60.0) |
• Yes | 4.15 (3.70–4.70) | 12.70 (8.70–13.20) | 0.06 (0.05–0.09) | 7.7 (7.3–8.3) | 30.0 (19.0–118.0) | 14.50 (1.09–23.09) |
Eye involvement | ||||||
• No | 3.75 (0.40–5.40) | 12.85 (4.20–13.30) | 0.08 (0.01–0.09)* | 8.3 (7.3–9.2) | 27.5 (9.0–131.0) | 6.73 (1.50–14.50) |
• Yes | 2.60 (0.77–9.60) | 9.90 (6.60–27.30) | 0.10 (0.03–0.30) | 7.8 (6.4–9.4) | 36.0 (10.0–141.0) | 3.16 (1.09–60.0) |
Nervous system involvement | ||||||
• No | 1.14 (0.77–1.50)* | 8.25 (7.30–9.20)* | 0.14 (0.03–0.25) | 7.9 (6.8–9.1) | 65.0 (60.0–100.0) | 31.56 (3.11–60.0) |
• Yes | 3.70 (0.40–9.60) | 12.85 (4.20–27.30) | 0.09 (0.01–0.30) | 8.0 (6.4–9.4) | 28.0 (9.0–141.0 | 2.94 (1.09–38.30) |
Major vessel involvement | ||||||
• No | 2.60 (0.40–9.60) | 9.90 (4.20–27.30) | 0.10 (0.03–0.30) | 8.0 (6.4–9.4) | 28.0 (9.0–141.0) | 3.11 (1.09–60.00) |
• Yes | 3.80 (3.70–4.20) | 13.25 (13.20–13.30) | 0.08 (0.01–0.09) | 8.0 (7.3–9.0) | 30.5 (30.0–131.0) | 13.00 (1.50–14.50) |